NEXGEL INC - COMMON S

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

12 авг 2024 06:15:00 Источник Nasdaq GlobeNewswire

NEXGEL Announces $1,110,000 Registered Direct Offering Led by Insiders

12 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

18 июл 2024 06:15:00 Источник Nasdaq GlobeNewswire

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

08 июл 2024 13:05:00 Источник Nasdaq GlobeNewswire

NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation

27 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

11 июн 2024 05:40:00 Источник Nasdaq GlobeNewswire

NEXGEL Acquires International Beauty Brand, Silly George

16 май 2024 06:00:00 Источник Nasdaq GlobeNewswire

NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year

13 май 2024 13:05:00 Источник Nasdaq GlobeNewswire

NEXGEL to Report First Quarter 2024 Financial Results on May 13th

09 май 2024 05:00:00 Источник Nasdaq GlobeNewswire

NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024

06 май 2024 13:05:00 Источник Nasdaq GlobeNewswire

NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024

18 апр 2024 05:00:00 Источник Nasdaq GlobeNewswire

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

01 апр 2024 04:50:00 Источник Nasdaq GlobeNewswire

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

27 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

21 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

04 мар 2024 05:30:00 Источник Nasdaq GlobeNewswire

NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders

21 фев 2024 13:05:00 Источник Nasdaq GlobeNewswire

NEXGEL to Present at The Microcap Conference, January 30th through February 1st

18 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

09 янв 2024 05:30:00 Источник Nasdaq GlobeNewswire

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

11 дек 2023 05:00:00 Источник Nasdaq GlobeNewswire

NEXGEL Acquires Kenkoderm Psoriasis Skincare Line

05 дек 2023 05:00:00 Источник Nasdaq GlobeNewswire